HIGHLIGHTS
- who: Katharina Schwarze from the United Kingdom United Kingdom United Kingdom have published the Article: The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom, in the Journal: (JOURNAL) of 30/07/2019
- future: Few studies have accounted for the number of samples that realistically must be sequenced to achieve a diagnostic result at least two samples are required for cancer cases and three are often required for rare disease cases with the proband and both parents often sequenced as a trio.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.